Azala

Mexico Pharmaceuticals Report - Q1 2025

Gorde:
Argitaratua izan da:Fitch Solutions Country Industry Reports (First Quarter 2025), p. 1
Argitaratua:
Fitch Solutions Group Limited
Gaiak:
Mexico
Pharmaceuticals
Statistical data
Industrywide conditions
Market analysis
Industry analysis
Business forecasts
SWOT analysis
Pharmaceutical industry
Sarrera elektronikoa:Citation/Abstract
Full Text - PDF
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
Laburpena:Despite challenges in drug procurement and patent enforcement, Mexico's pharmaceutical industry is poised for long-term growth. This anticipated expansion is driven by the rising demand for advanced treatments for chronic diseases. As the second largest pharmaceutical market in Latin America, Mexico presents significant opportunities for companies developing innovative medications. However, relatively low per capita spending on pharmaceuticals may limit the widespread adoption of patented drugs, potentially increasing the market share of generics. Government initiatives to enhance local drug manufacturing are likely to encourage more international partnerships, especially in technological exchange.
ISSN:2976-4750
Baliabidea:ABI/INFORM Trade & Industry